SNOA vs TECH · rev $19.5M vs P/E 65, rev $1.22B
Sonoma Pharmaceuticals Inc (SNOA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
SNOA currently screens at market cap $4.9M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the SNOA and TECH stock pages for the full models.
Not investment advice.